Improving patient quality of life
With demonstrated clinical development and commercialization expertise, VIVUS is dedicated to addressing the therapeutic needs of patients with serious medical conditions and life-limiting diseases.
Our growing portfolio of products
PANCREAZE® for Exocrine Pancreatic Insufficiency (EPI)
Exocrine pancreatic insufficiency (EPI) is a condition that results from a deficiency in the production and/or secretion of pancreatic enzymes and can lead to chronic diarrhea, significant weight loss and malnutrition. While there is no cure for EPI, PANCREAZE, a pancreatic enzyme replacement therapy, is an effective therapy for managing this chronic disease.
Latest Press Releases
VIVUS Locations and Contact Information
To access our corporate contact directories please select from:
Helpful Links and Resources
LOCATIONS
ABOUT VIVUS